SCHEMBL19903685

SCHEMBL19903685

N#Cc1cc(-n2c3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)cc3c3cc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)ccc32)c(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)c(-n2c3ccc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)cc3c3cc(-c4ccc(C(F)(F)F)cc4C(F)(F)F)ccc32)c1

nearest known ligand 0.36

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 2/20 0.36
FEN1 P39748 2/20 0.36
RXRA P19793 1/20 0.35
RXRG P48443 1/20 0.35
KIF11 P52732 2/20 0.35
AR P10275 1/20 0.33
CETP P11597 1/20 0.32
CYP2C9 P11712 1/20 0.32
SCN9A Q15858 1/20 0.32
PTGDR2 Q9Y5Y4 1/20 0.31
EDNRB P24530 1/20 0.31
EDNRA P25101 1/20 0.31
DGAT1 O75907 1/20 0.31
SOAT1 P35610 1/20 0.31
KCNH2 Q12809 1/20 0.31
XDH P47989 3/20 0.31
SLC22A12 Q96S37 2/20 0.31
NSD2 O96028 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20617429 0.98 RXRA (0.38) ALOX5APFEN1RXRARXRGKIF11
SCHEMBL19903676 0.95 AR (0.34) ALOX5APFEN1RXRARXRGKIF11
SCHEMBL21414156 0.95 ALOX5AP (0.36) ALOX5APFEN1RXRARXRGKIF11
SCHEMBL20617426 0.93 RXRA (0.35) ALOX5APFEN1RXRARXRGKIF11
SCHEMBL21258763 0.92 ALOX5AP (0.38) ALOX5APFEN1RXRARXRGKIF11
SCHEMBL20112042 0.92 RXRA (0.38) ALOX5APFEN1RXRARXRGKIF11
SCHEMBL19903686 0.92 ALOX5AP (0.36) ALOX5APFEN1RXRARXRGKIF11
SCHEMBL21414194 0.90 AR (0.35) ALOX5APFEN1RXRARXRGKIF11
SCHEMBL21546628 0.90 PTGDR2 (0.40) ALOX5APFEN1KIF11ARCETP
SCHEMBL25659059 0.89 KIF11 (0.38) ALOX5APFEN1RXRARXRGKIF11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-10-08 US disclosed
EP-3360945-B1 ORGANIC ELECTROLUMINESCENT DEVICE CYNORA GMBH (DE) 2019-04-24 EP disclosed
EP-3287450-B1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2019-03-20 EP disclosed
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
EP-3287450-A1 ORGANIC MOLECULES, IN PARTICULAR FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-02-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10439151-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, ORC3, AOC3 ALOX5AP 3371/4885FEN1 1443/4885RXRA 3779/4885
US-20180062086-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, ORC3, AOC3 ALOX5AP 3376/4885FEN1 1603/4885RXRA 3635/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.